Tech Company Financing Transactions

Apreo Health Funding Round

Bain Capital Life Sciences, Norwest Venture Partners and F-Prime Capital invested in a $130 million Series B capital raise for Apreo Health. The funding round was announced on 8/7/2025.

Transaction Overview

Company Name
Announced On
8/7/2025
Transaction Type
Venture Equity
Amount
$130,000,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to accelerate its regulatory activities related to BREATHE-3 and early commercialization efforts to demonstrate strong market potential.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4040 Campbell Ave 210
Menlo Park, CA 94025
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Apreo Health is dedicated to pioneering safe, transformative solutions for lung disease. We serve patients with passion, integrity and a commitment to restoring their health and quality of life.
Profile
Apreo Health LinkedIn Company Profile
Social Media
Apreo Health Company Twitter Account
Company News
Apreo Health News
Facebook
Apreo Health on Facebook
YouTube
Apreo Health on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Karun Naga
  Karun Naga LinkedIn Profile  Karun Naga Twitter Account  Karun Naga News  Karun Naga on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/7/2025: Build on Bitcoin venture capital transaction
Next: 8/7/2025: Capacity venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to record every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary